Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ImmunoGen -- Ignore unavailable to you. Want to Upgrade?

To: RJMC who wrote (3810)	1/24/2001 1:01:16 PM
From: NRugg	Read Replies (1) \| Respond to of 5665

New Biotech Index Most posters seem to feel that the inclusion of IMGN in the revised NASDAQ Biotech Index was the main reason for the big jump in price on January 23. What intrigued me was that this jump was accomplished with only 840,000 shares, slightly less than the average of 902,000 according to Yahoo. The last time IMGN made a similar jump of about 4 points, Nov 1, it took 1,407,000 shares. I can't believe that the Jan 23 announcement took Barkleys by surprise either. I did me, and I guess a lot of retail investors who had been sitting on the sidelines. Norman